BOWIE, Md. — Inovalon announced a long-term engagement with Walmart’s Specialty Pharmacy business to provide cloud-based capabilities through the Inovalon ONE Platform as part of its data-driven strategy to improve outcomes and economics for its customers.

The high-complexity and high-cost nature of specialty pharmacy stands to benefit significantly from the capabilities enabled through the Inovalon ONE Platform. Through the implementation of ScriptMed Cloud, a software-as-a-service (SaaS) cloud offering configured to address the unique needs of specialty pharmacy demands, the Inovalon ONE Platform’s connectivity, supplemental clinical data, and process-specific analytics automate otherwise labor-intensive processes, pre-populate relevant clinical data, seamlessly apply appropriate care protocol analytics, and streamline operational process flows – ultimately enabling improvements in quality of care and operating expense efficiency at scale.

The Inovalon ONE Platform will facilitate coordination of specialty medication dispensing from Walmart’s Specialty Pharmacy and available across Walmart’s extensive network of thousands of retail pharmacies, enabling Walmart in helping its customers achieve their best health, decrease prescription time-to-fill, lower costs-to-fill, and enhance key operational flexibilities and strategic insights key to very-large-scale operations.

“Our specialty pharmacy mission is to provide a flexible, dual-channel, patient-centric model that fosters positive clinical outcomes, great customer experiences, and everyday low price. Our patient approach is personalized and caring – designed to empower and inspire patients to choose healthy behaviors and live better,” said Mike Adloo, specialty lead health and wellness, Walmart.  “Inovalon’s capabilities in the specialty pharmacy market will play an integral role in support of our mission – delivering the best possible quality outcomes and experience for our patients while lowering their costs.”

“Specialty pharmacy is a uniquely high-value segment of the healthcare ecosystem that is of increasing importance to payers, pharmaceutical companies and patients alike. The unique combination of our platform’s capabilities is highly differentiated within the marketplace, and a true thrill to bring to bear for such an industry leader as Walmart,” said Dr. Keith Dunleavy, chief executive officer of Inovalon. “Their clear focus on the customer, their experience, their outcomes, and their costs is remarkable.”